معرفی
Dr. Marloes Bazelier holds dual roles as a part-time researcher/data manager at Utrecht University's Division of Pharmacoepidemiology and Clinical Pharmacology (Faculty of Science) and a part-time pharmacoepidemiology expert at the Dutch Medicines Evaluation Board. She obtained her MSc in Mathematics and PhD (2012) from Utrecht University, with doctoral research focusing on fracture risk in multiple sclerosis and diabetes using multinational healthcare databases.
Research Focus: Her work centers on pharmacoepidemiology, drug safety, and real-world data analytics. Key interests include:
- Risk assessment of medication-related complications (fractures, infections, cancer)
- Methodologies for multi-database studies
- Diabetes, multiple sclerosis, and cardiovascular outcomes
- Real-world evidence generation for regulatory science
Publications: Her recent articles demonstrate strong emphasis on pharmacoepidemiological methods, multi-database analyses, and drug safety in chronic diseases. Recurring themes include diabetes therapies, neurological disorders, and cancer risk, often leveraging large-scale healthcare datasets from multiple countries. Methodological rigor in handling real-world data is a consistent focus.
Leadership & Service:
- Supervises three PhD students
- Associate Editor for Pharmacoepidemiology and Drug Safety
- Leads data management standards development at Utrecht University
- Organizes weekly divisional research symposia
- Member of Methodology and Real World Evidence groups at Dutch Medicines Evaluation Board
